| ¿µ¹® | cohort study | ÇÑ±Û | °èȹ¿¬±¸, ÀüÇ⿬±¸, ¾Õ¹æÇ⿬±¸ |
|---|---|---|---|
| ¼³¸í | ºÐ¼®¿ªÇп¡¼ÀÇ ¿äÀÎ-´ëÁ¶¿¬±¸ÀÇ ÇÑ ±â¹ýÀÌ´Ù. »ç¶÷ÀÇ Áý´Ü¿¡¼ Áúº´À¯Çà°ú °¡¼³¿äÀΰúÀÇ ¿¬°ü¼ºÀ» °íÂûÇÏ¿© Àΰú°ü°è¸¦ ¹àÈ÷´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. °¡¼³¿äÀÎÀ» °®´Â Áý´Ü°ú °®Áö ¾Ê´Â Áý´Ü, ȤÀº ÀûÀº Áý´Ü°ú ¸¹Àº Áý´ÜÀÇ 2±º(ÄÚȣƮ)À¸·Î ³ª´©¾î ÃßÀû Á¶»çÇÏ¿© °¢ Áý´Ü¿¡¼ÀÇ Áúº´ÀÇ ¹ß»ýºóµµ¸¦ ºñ±³ÇÏ´Â °ÍÀÌ´Ù. ÀϹÝÀûÀ¸·Î´Â ÀüÇâÀûÀÎ ¿¬±¸·Î ÇàÇØÁö´Â °æ¿ì°¡ ¸¹À¸³ª ÈÄÇâÀûÀÎ ¿¬±¸·Îµµ ÇàÇÏ¿©Áø´Ù. |
||
| ¿µ¹® | fertility | ÇÑ±Û | »ý½Ä´É·Â, Ãâ»ê·Â |
|---|---|---|---|
| ¼³¸í | 1. ¼öŸ¦ ÇÒ ¼ö ÀÖ´Â °Í 2. °¡ÀÓ ¿¬·ÉÀÇ ¿©¼º ¼ö¿¡ ´ëÇÑ Àϳ⠵¿¾ÈÀÇ Ãâ»ý¼öÀÇ ºñÀ². |
||
| APS | adenosine phosphosulfate; American Pain Society; American Pediatric Society; American Physiological ... |
|---|---|
| AES | acetone-extracted serum; American Electroencephalographic Society; American Encephalographic Society... |
| proc | proceedings, procedure; process |
| NFS | National Fertility Study; no fracture seen |
| AFS | acquired or adult Fanconi syndrome; alternative financing system; American Fertility Society; antifi... |
| AFS | Americal Fertility Society |
|---|---|
| RAFS | Revised American Fertility Society |
| TFR | Total Fertility Rate |
| Study 1 | study |
| Study 2 | study |
| American Cancer Society | <address, organisation> American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA. Tel: 00 1 404 320-3333 (05 Feb 1998) |
|---|---|
| general fertility rate | A refined measure of fertility in a population; the numerator is the number of live births in a year, the denominator is the number of females of child-bearing age, usually defined as ages 15-44 (but increasingly recognised as extending to age 49). (05 Mar 2000) |
| total fertility rate | <epidemiology> The number of children an average women would have assuming that she lives her full reproductive lifetime. (05 Dec 1998) |
| fertility | <biology> The capacity to conceive or induce conception and thus generate offspring. (12 May 1997) |
| fertility agent | The prototype conjugative plasmid associated with conjugation in the K-12 strain of Escherichia coli. Synonym: F agent, F-factor, F genote, F-genote, fertility agent, fertility factor, sex factor. (05 Mar 2000) |
| fertility agents | Drugs used to increase fertility or to treat infertility. (12 Dec 1998) |
| fertility agents, female | Compounds which increase the capacity to conceive in females. (12 Dec 1998) |
| fertility agents, male | Compounds which increase the capacity of the male to induce conception. (12 Dec 1998) |
| fertility factor | The prototype conjugative plasmid associated with conjugation in the K-12 strain of Escherichia coli. Synonym: F agent, F-factor, F genote, F-genote, fertility agent, fertility factor, sex factor. (05 Mar 2000) |
| fertility ratio | A measure of the fertility of a population based on the female population in the child-bearing age-group, defined as ages 15-49 years. (05 Mar 2000) |
| fertility vitamin | <biochemistry> Functions as an antioxidant, binds oxygen free radicals that can cause tissue damage, may also play a protective role in the coronary arteries from the damaging effects of cholesterol. (27 Sep 1997) |
| analytic study | In epidemiology, a study designed to examine associations, commonly putative or hypothesised causal relationships; usually concerned with identifying or measuring the effects of risk factors or with the health effects of specific exposures. (05 Mar 2000) |
| blinded study | Clinical trials of drugs are often done blinded so that the patient does not know (is blinded as to) whether they are receiving the product being tested or the control/placebo to ensure that the results of a study are not affected by a possible placebo effect (by the power of suggestion). (12 Dec 1998) |
| blind study | A study in which the experimenter is unaware of which group is subject to which procedure. (05 Mar 2000) |
| case-control study | <epidemiology> A study in which the risk factors of people with a disease are compared with those without a disease. It is an epidemiological method that begins by identifying persons with the disease or condition of interest (the cases) and compares their past history of exposure to identified or suspected risk factors with the past history of similar exposures among persons who resemble the cases but do not have the disease or condition of interest (the controls). The relationship of an attribute to the disease can therefore be examined by comparing affected and non-affected individuals with regard to the frequency or levels of the attribute in each group. (05 May 2002) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|